Clinical Trials Browser

Central Nervous System Neoplasms × Postoperative Period × CNS × Clear all

NCT03965494 2024-02-08

AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing Surgery

Phase EARLY_PHASE1 Terminated

Glioblastoma, Central Nervous System Neoplasms